Dr Reddy’s to acquire Nicotinell and related portfolio
The portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
NIDO Group partners with 1Pharmacy to digitise supply chain
This partnership aims to optimise operations and digitalise the value chain for efficient and streamlined processes
Cipla signs agreement with Takeda to commercialise Vonoprazan
This deal is meant to commercialise the drug in India under Cipla’s own trademark brands
Suven to acquire controlling stake in Sapala Organics, a CDMO player
Suven has agreed to acquire an initial controlling stake, operate the business together with the selling shareholders for the next…
Lupin, Fuji sign agreement to commercialise Nextstellis in Vietnam, Philippines
Lupin, Fuji sign agreement to commercialise Nextstellis in Vietnam, Philippines
M&A trends to watch out in pharma
Aditya Patni, Partner; Achint Kaur and Siddharth Marwah, Counsels at Khaitan & Co decode and decipher factors spurring…
Kotak Alt acquires API business of Matrix Pharma
Kotak Alt invests Rs 1445 Cr for the acquisition, aims to strengthen Matirx’s API business by third-party sales and selectively…
Syntegon acquires Telstar
Telstar will join the Germany-based company following the transaction, announces Azbil Corporation and Syntegon
Good Monk raises Rs. 7 crores in pre-series A round
Good Monk secures funding from Multiply Ventures, Sharrp Ventures and Thinkuvate
Andelyn Biosciences selected to manufacture AAV therapies under CIRM
The partnership aims to advance BGTC’s mission to develop platforms and standards to propel the development and delivery of…
SII invests in IntegriMedical’s Needle-Free Injection System technology
With this investment, SII will acquire a 20 per cent stake in IntegriMedical. Reportedly, the investment is expected to accelerate…
Zydus, MSN partner to license and supply Cabozantinib Tablets for the US
As per the agreement, MSN will manufacture and supply the generic version of CABOMETYX and Zydus will exclusively market,…
Biocon signs deal with Medix to market generic Saxenda in Mexico
Biocon will undertake the responsibility of obtaining regulatory approval, manufacturing and supply of the drug product, and Medix…
Q12024 funding in pharma, healthcare dips 70% from Q4 2023
As per Tracxn.com data, 58.5 per cent of funding in Q12024 in early-stage rounds
Bora Pharmaceuticals acquires Upsher-Smith
The acquisition expands Taiwan-based Bora’s North American footprint with its first US manufacturing site
Biocon Biologics sells branded formulations biz to Eris Lifesciences for INR12.42 bn
Includes portfolio of metabolics, oncology, and critical care products in India and a 10-year supply agreement with Eris
Deal value increased by 19.2 per cent in Jan 2024, compared to Jan 2023: GlobalData
VC investments increased by 11.2 per cent in Jan 2024, compared to Jan 2023
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone
Sun Pharma to market the drug under the brand name Lyvelsa
Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report
The quarter saw 26 deals totalling $2.7 billion, with a 32 per cent decline in deal volumes compared to Q3 2022